Paracetamol/Codeine phosphate hemihydrate Accord 500 mg/30 mg tablets
Sponsors
Novartis Pharma AG
Conditions
Knee OsteoarthritisKnee osteoarthritis
Phase 2
A randomized, two-arm, placebo-controlled, participant, investigator and sponsor-blinded, proof-of-concept study investigating the efficacy, safety and tolerability of QUC398 in patients with symptomatic knee osteoarthritis
CompletedCTIS2023-509274-28-00
Start: 2023-02-03End: 2025-04-08Target: 76Updated: 2024-12-20
A randomized, two-arm, placebo-controlled, participant and investigator-blinded study investigating the efficacy, safety and tolerability of DFV890 in patients with symptomatic knee osteoarthritis
CompletedCTIS2023-507559-30-00
Start: 2021-11-09End: 2024-12-19Target: 76Updated: 2024-12-16